Status: Recruiting
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer
This will be a multi-center, randomized, open-label, parallel-group study in adult patients with head and neck cancer.
Participants needed: 30
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: VSPharmTech Co.,Ltd.Updated: Jun 22, 2026Locations: 2
Eligibility criteria
Males or females aged more than 18 years at the time of ICF signing [+12]
Medical History [+24]